Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Longevity Plus, LLC
WARNING LETTER
•Longevity Plus, LLC•July 31, 2010

Longevity Plus, LLC – FDA Warning Letter, Jul 31, 2010

Record Details

The FDA issued a Warning Letter to Longevity Plus on October 12, 2010, following a July 2010 review of their website, www.longevityplus.com. The FDA determined that Longevity Plus's products "Beyond Chelation Improved," "EndoKinase," "Viral Defense," and "Wobenzym-N 200ct" are promoted with therapeutic claims that classify them as drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act). These claims, found on Longevity Plus's website and a linked site, www.gordonresearch.com (operated by Longevity Plus consultant Garry F. Gordon, MD), suggest the products are intended for the cure, mitigation, treatment, or prevention of diseases such as cancer, heart disease, strokes, blood clots, hypertension, influenza, herpes, hepatitis C, autoimmune diseases, and various inflammatory conditions.

Since these products are not generally recognized as safe and effective for these uses, they are considered "new drugs" under section 201(p) of the Act. Marketing new drugs without prior FDA approval, as required by section 505(a) of the Act, is a violation. The letter states that the listed violations are not exhaustive and that other products on their website also make unlawful disease treatment and prevention claims. Longevity Plus is required to take prompt action

Company
Longevity Plus, LLC
Inspection date
July 31, 2010
Product type
Drugs
Office
Los Angeles District Office
Person
  • Alonza E. Cruse (Director)
View Company Profile

ID · 242f515d-b78c-498a-9faa-6d351095c4c9

Violation Codes5
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 33221 U.S.C. 334

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Longevity Plus, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.